Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Deloitte
McKinsey
Cerilliant
Chinese Patent Office
US Army
Cipla
Argus Health
Daiichi Sankyo

Generated: September 23, 2018

DrugPatentWatch Database Preview

Butorphanol tartrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for butorphanol tartrate and what is the scope of butorphanol tartrate freedom to operate?

Butorphanol tartrate is the generic ingredient in four branded drugs marketed by Baxter Hlthcare Corp, Hikma Farmaceutica, Hospira, West-ward Pharms Int, Apothecon, Apotex Inc, Mylan, and Bristol Myers Squibb, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for butorphanol tartrate. Five suppliers are listed for this compound.

Pharmacology for butorphanol tartrate
Medical Subject Heading (MeSH) Categories for butorphanol tartrate
Synonyms for butorphanol tartrate
(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol
(-)-butorphanol
(-)-N-cyclobutylmethyl-3,14-dihydroxymorphinan
(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.0;{1,10}.0;{2,7}]heptadeca-2(7),3,5-triene-4,10-diol
(1S,9R,10S)-17-(CYCLOBUTYLMETHYL)-17-AZATETRACYCLO[7.5.3.0(1),(1)?.0(2),?]HEPTADECA-2(7),3,5-TRIENE-4,10-DIOL
17-(CYCLOBUTYLMETHYL)MORPHINAN-3,14-DIOL
42408-82-2
50807-69-7
58786-99-5
AN-6427
API0009093
BC 2627
BC-2627
BDBM50240437
Beforal
Beforal (TN)
BIDD:GT0549
Butorfanol
Butorfanol [INN-Spanish]
butorphanol
Butorphanol (USAN/INN)
Butorphanol [USAN:BAN:INN]
Butorphanol [USAN:INN:BAN]
Butorphanolum
Butorphanolum [INN-Latin]
C-33046
C06863
CHEBI:3242
CHEMBL33986
CTK7J9662
D03197
D0X9RG
DEA No. 9720
dl-3,14-Dihydroxy-N- morphinan
DTXSID1022714
EINECS 255-808-8
FT-0664002
GTPL7591
IFKLAQQSCNILHL-QHAWAJNXSA-N
J-504151
L-3,14-dihydroxy-N-(cyclobutylmethyl)morphinan
l-BC 2627
L-N-Cyclobutylmethyl-3,14-dihydroxymorphinan
levo-BC-2627
LS-91729
Moradol
Moradol (TN)
Morphinan-3,14-diol, 17-(cyclobutylmethyl)-
N-cyclobutylmethyl-3,14-dihydroxymorphinan
PL006230
Q-200770
QV897JC36D
SCHEMBL3749
Stadol
Stadol NS
UNII-QV897JC36D
ZINC3812988

US Patents and Regulatory Information for butorphanol tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon STADOL PRESERVATIVE FREE butorphanol tartrate INJECTABLE;INJECTION 017857-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon STADOL butorphanol tartrate INJECTABLE;INJECTION 017857-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hikma Farmaceutica BUTORPHANOL TARTRATE butorphanol tartrate INJECTABLE;INJECTION 078400-001 May 1, 2009 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int BUTORPHANOL TARTRATE butorphanol tartrate SPRAY, METERED;NASAL 075824-001 Mar 12, 2002 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for butorphanol tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apothecon STADOL PRESERVATIVE FREE butorphanol tartrate INJECTABLE;INJECTION 017857-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Bristol Myers Squibb STADOL butorphanol tartrate SPRAY, METERED;NASAL 019890-001 Dec 12, 1991 ➤ Sign Up ➤ Sign Up
Apothecon STADOL PRESERVATIVE FREE butorphanol tartrate INJECTABLE;INJECTION 017857-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Deloitte
McKinsey
Cerilliant
Chinese Patent Office
US Army
Cipla
Argus Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.